about
The binary protein interactome of Treponema pallidum--the syphilis spirocheteThe protein interaction map of bacteriophage lambdaEvolutionarily conserved herpesviral protein interaction networksThe Protein Interaction Network of Bacteriophage Lambda with Its Host, Escherichia coliStudying protein complexes by the yeast two-hybrid systemThe Escherichia coli K-12 ORFeome: a resource for comparative molecular microbiologyThe protein network of bacterial motilityAnalysis of protein-protein interactions using array-based yeast two-hybrid screens.Analysis of protein-protein interactions using high-throughput yeast two-hybrid screens.The binary protein-protein interaction landscape of Escherichia coliMatrix-based yeast two-hybrid screen strategies and comparison of systems.Array-based yeast two-hybrid screens: a practical guide.Benchmarking yeast two-hybrid systems using the interactions of bacterial motility proteinsMining host-pathogen protein interactions to characterize Burkholderia mallei infectivity mechanisms.Mapping the Protein-Protein Interactome Networks Using Yeast Two-Hybrid Screens.Using host-pathogen protein interactions to identify and characterize Francisella tularensis virulence factors.Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis.Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus).The Human Microbiome and Cancer.Exhaustive benchmarking of the yeast two-hybrid system.7 Array-Based Yeast Two-Hybrid Screening for Protein–Protein Interactions
P50
Q21144302-DAF7D0DB-B8EB-4E54-A0E6-85D351F07E70Q21263111-6DA93726-88D3-40D0-827F-CAAC02FFAC97Q21559419-0599C651-0EDA-4C88-845B-9590C35347F1Q22061801-159ED508-D099-46AD-BC16-112D089ABA5EQ24601982-3F3D72ED-D138-4A00-904F-11AC7FBCC03EQ28290208-55BD7919-8990-49C4-A736-9C9CACCE9E12Q33280571-76640059-34A1-4A3E-BE19-CA5D3A90539DQ33466869-9DFD2D4A-6A9B-42A8-A358-5F0BE34AF4D4Q34005662-37559D60-15F8-406E-AEAC-49C0CFAD6B17Q34010755-FA6E3BFB-62EC-4D83-B2B6-3DC6F41F7238Q34118745-E97AB961-002D-4770-A652-3185F6761743Q34118751-3D5C284F-7C3E-4226-AC8F-B5C993CDEA5CQ35008242-F08F6668-9DBB-495A-B509-E89046D6CC9AQ35147602-02F9D5DC-544A-44D2-96FC-CD580F7EE8D8Q35856479-9F8689FA-06ED-4BDC-9E56-DA490BC419E6Q35881003-36FB0DD9-32B7-4215-8FFF-DDA60E69B461Q36104405-EAA147BB-9EB5-4771-BD32-388329074327Q37395513-C0635DC5-B856-490E-AF7E-25BA6E0CA2A8Q39092607-1CE816C2-CB41-432C-835E-D228AA4E895BQ55053371-6514FB28-E207-4CD2-A875-AD934F5A1623Q57985604-9E6A2A10-BF45-4C3C-A2FC-19388C21373B
P50
description
medical researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Seesandra Rajagopala
@fr
Seesandra V Rajagopala
@es
Seesandra V Rajagopala
@nl
Seesandra V Rajagopala
@sl
Seesandra V. Rajagopala
@en
type
label
Seesandra Rajagopala
@fr
Seesandra V Rajagopala
@es
Seesandra V Rajagopala
@nl
Seesandra V Rajagopala
@sl
Seesandra V. Rajagopala
@en
prefLabel
Seesandra Rajagopala
@fr
Seesandra V Rajagopala
@es
Seesandra V Rajagopala
@nl
Seesandra V Rajagopala
@sl
Seesandra V. Rajagopala
@en
P106
P21
P31
P496
0000-0001-7176-5770